Regeneron Pharmaceuticals received past FDA approval for Livsayis (cemdisiran) to treat anti acetylcholine receptor antibody positive generalized myasthenia gravis in adults, based on Phase 3 NIMBLE ...
Source LinkRegeneron Pharmaceuticals received past FDA approval for Livsayis (cemdisiran) to treat anti acetylcholine receptor antibody positive generalized myasthenia gravis in adults, based on Phase 3 NIMBLE ...
Source Link
Comments